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Impairment of the hepatic transport of bile acids and other organic anions will
result in the clinically important syndrome of cholestasis. Cloning of a number
ofspecific hepatic organic anion transporters has enabled studies oftheir mole-
cular regulation during cholestasis. The best characterized transport system is a
50-51 kDa sodium-dependent taurocholate cotransporting polypeptide (ntcp),
which mediates the sodium-dependent uptake of conjugated bile acids at the
sinusoidal plasma membrane ofhepatocytes. Under physiologic conditions and
after depletion of biliary constituents, ntcp remains constitutively expressed
throughout the liver acinus. However, both function and expression of ntcp are
rapidly down-regulated in rat liver in various models of experimental cholesta-
sis, such as cholestasis induced by common bile duct ligation, estrogen, endo-
toxin or cytokine treatment. In addition to ntcp, the sinusoidal organic anion
transporting polypeptide oatp-1 is also down-regulated at the protein and
steady-state mRNA levels in estrogen-cholestasis, but does not affect sodium-
independent uptake of taurocholate. The regulation of a recently cloned mem-
ber of the organic anion transporter family (oatp-2), which is highly expressed
in liver, remains to be studied under cholestatic conditions.
INTRODUCTION
Bile formation is an important function of the liver cell to excrete lipophilic organic
anions, such as bile acids, bilirubin, steroids and xenobiotics, as well as cholesterol, either
directly or by conversion of cholesterol into bile acids. Furthermore, bile plays an impor-
tant role in the digestion and uptake ofdietary lipids and lipophilic vitamins in the intes-
tine [1].
Bile flow is driven by generating osmotic gradients between portal blood, hepatocytes
and the bile canaliculus. Organic anions, especially bile acids and their taurine and glycine
conjugates, are the most important osmotically active solutes [2]. They generate the bile
acid dependent bile flow, which accounts for at least 50 percent of total bile flow in all
species. In addition, bile acid independent bile flow is generated by canalicular secretion
of glutathione and bicarbonate, and its proportion of total bile flow varies among differ-
ent species. After synthesis by the hepatocytes, bile acids undergo an efficient enterohep-
atic circulation, which includes excretion into bile, delivery to the intestine, absorption in
the ileum, transport to the liver via the portal blood and final reabsorption by the hepato-
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cytes [3]. Only 5 percent of the total bile acid pool is daily lost by the feces and must be
replaced by de novo synthesis in the liver.
BILE ACID TRANSPORT SYSTEMS IN THE LIVER
The current understanding ofthe vectorial transport ofbile acids in the liver is based
on the concept that hepatocytes are classical epithelial cells, which are highly polarized
with respect to transport systems at the basolateral (sinusoidal) and apical (canalicular)
plasma membranes [4]. The inorganic ion transporter Na+-K+-ATPase is exclusively
localized at the basolateral plasma membrane ofhepatocytes and maintains ion gradients
necessary for driving secondary and tertiary active transport systems. This cation pump
exchanges three intracellular sodium ions for two extracellular potassium ions, thereby
generating an inwardly directed sodium gradient and an outwardly directed potassium
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Figure 1: Schematic illustration of basolateral and canalicular bile acid and organic anion
transporters in rat hepatocytes. At the basolateral plasma membrane uptake of conjugated bile
acids (BA-) occurs by the sodium-dependent taurocholate cotransporting polypeptide (ntcp). At
least two multispecific organic anion transporters (oatp-l, oatp-2) mediate the uptake ofa variety of
organic anions (OA-) including bile acids. The physiological driving force of both oatps remains
still unknown. At the canalicular plasma membrane monovalent bile acids are secreted into the bile
canaliculus (BC) by the ATP-dependent bile acid transporter (cBAT), whereas divalent organic
anions are transported by the canalicular multi-organic anion transporter (cMOAT). The latter has
recently been shown to be identical with a canalicular isoform of the multidrug resistance protein
(mrp2). The contribution of a potential driven pathway for secretion ofmonovalent bile acids at the
canalicular membrane remains controversial.
gradient [5]. In addition to maintaining ion gradients, the Na+-K+-ATPase generates intra-
cellularly a negative electrical potential, which drives uptake and secretion of positively
and negatively charged solutes, respectively. Regarding bile acid transport, five different
carriers have been identified at these domains [6, 7] (Figure 1).
The best characterized transporter is a secondary active, sodium-dependent bile acid
uptake system at the basolateral membrane, which mediates a high affinity uptake ofcon-
jugated bile acids (Km 10-30 ,uM) from the portal blood. This transport system represents
a 50-51 kDa taurocholate cotransporting polypeptide (ntcp/NTCP) and the genes encoding
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these proteins have recently been cloned from rat and human liver [8-11]. The second
transport system belongs to a growing family of organic anion-transporters and was the
first to be identified in rat liver by expression cloning [12]. This organic anion transport-
ing polypeptide (oatp-1), with an apparentmolecular weight of80kDa, mediates the sodi-
um-independent uptake of a broad spectrum of amphipathic compounds, such as organic
anions (e.g., bile acids and bromosulphthalein (BSP), anionic steroid conjugates (e.g.,
estrone 3-sulfate and estradiol 17B-glucuronide), neutral steroids (e.g., aldosterone,
ouabain) and some organic cations (e.g., N-(4,4-azo-n-pentyl)-21-deoxyajmaline) [13,14].
A cloned human OATP has also been shown to transport independent of sodium similar
substrates as the rat liver oatp-1 including bile salts and BSP [15, 16]. A third member of
the oatp/OATP family with a 37 percent amino acid identity with the rat liver oatp-1 may
be involved in the transport of prostaglandins in rats [17]. Finally, an additional organic
anion transporter (oatp-2) with high expression in rat liver mediates the uptake of tauro-
cholate and cholate as well as digoxin after expression in Xenopus laevis oocytes [7].
After translocation ofbile acids across the hepatocytes, two different active transport
systems at the canalicular domain of the hepatocytes are involved in the secretion of bile
salts into the bile canaliculus. Canalicular excretion ofbile salts, which represents the rate
limiting step in overallhepatic bile acid transport, generates an osmotic gradientby amore
than 100-fold concentration of bile salts within the bile canaliculus over that of the liver
cells and portal blood. This gradient leads to passive influx of water and electrolyte from
the liver cell and via the paracellularpathway. Secretion ofmonovalent bile acids is main-
ly mediated by anATP-dependent bile acid transporter, which has functionally been char-
acterized [18-21]. Preliminary data suggest that the canalicular bile acid transportermight
be identical to the recently cloned sister-p-glycoprotein, a member of the ATP-binding
cassette superfamily [22]. Sulphated and glucuronidated bile acids are substrates of the
canalicularmultiorganic anion transporter(cMOAT), which has recently been shown to be
identical with a canalicular isoform of the multidrug resistance-associated protein mrp2
[23-26]. mrp2 is notexpressed in TRlGY-rats and its protein is absent in patients with the
Dubin-Johnson syndrome due to a mutation in the mrp2/cMOAT gene [25, 27, 28]. In
addition to ATP-dependent transport, potential driven canalicular secretion of bile acids
has been demonstrated in isolated perfused livers and hepatocytes couplets [5]. However,
its present role in overall canalicular secretion of bile acids remains controversial, since
subfractionation studies using free-flow electrophoresis have localized electrogenic tauro-
cholate transport almost exclusively to the endoplasmic reticulum, whereas ATP-depen-
dent transport of taurocholate was confined to the canalicular membrane and a subapical
compartment [29].
Impairment offunction andexpression ofeither theNa+-K+-ATPase or any ofthe bile
acid transporters might result in cholestasis characterized by reduced bile flow, retention
ofbiliary constituents including bilirubin and bile acids, and clinically important features
such as jaundice and pruritus. Although changes in transporter function have been
described for some of these transporters in a variety of experimental models of cholesta-
sis, cloning of ntcp, members ofthe oatp/OATP-family and cMOAT/mrp2 has enabled for
the first time studies of their molecular regulation under cholestatic conditions. Cloning
of the canalicularATP-dependent bile acid transporter will close a major gap in our cur-
rent understanding ofhepatic bile acid transport within the near future.
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FUNCTION AND EXPRESSION OF THE
NA+-K+-ATPASE DURING CHOLESTASIS
Although Na+-K+-ATPase plays an important role in maintaining the functional
polarity of the hepatocytes and driving secondary and tertiary active transport systems
(e.g., the sodium-dependent uptake ofbile acids, amino acids and glucose), little is known
about its function and expression under various cholestastic conditions. Na+-K+-ATPase
is a transmembrane protein and consists in the liver of a large 112-kDa catalytic subunit
(al-subunit) and a 50-kDa glycoprotein(BI-subunit) ofunknown function. Changes in the
activity of Na+-K+-ATPase correlate with similar alterations of the bile acid independent
bile flow [5]. The best studied model of experimental cholestasis affecting Na+-K+-
ATPase activity has been the cholestasis induced by synthetic estrogens in rat liver (e.g.,
ethinyl estradiol 5 mg/kg body weight for 5 days). Most studies demonstrate a decrease in
Na+-K+-ATPase activity by about 50 percent within 1-5 days of treatment with estrogens
[30]. Whereas expression of both al and PI3-subunits remained unchanged at the protein
and mRNA levels [30], decrease in Na+-K+-ATPase activity has been attributed to changes
in membrane fluidity, which is reversible by treatment of membranes with Triton WR
1339 and can be prevented by simultaneous application ofS-adenosyl-L-methionine [31].
Although taurocholate uptake is markedly diminished in estrogen-induced cholestasis,
reduced Na+-K+-ATPase activity does not seem to be of any pathophysiological signifi-
cance regarding bile acid transport. Normalization offluidity in vitro does not prevent the
decrease in taurocholate uptake and reduced Na+-K+-ATPase activity has been associated
with both decreased bile flow after estrogen treatment and increased bile flow after treat-
ment with spironolactone [30, 32-34]. In endotoxin-induced cholestasis a similardecrease
in Na+-K+-ATPase activity by about 50 percent of controls and a reduction in bile flow
and taurocholate uptake, respectively, have been reported by several investigators [35-37],
but protein and mRNA expression at least ofthe al-subunit remained unchanged. In con-
trast to sodium-dependent uptake of taurocholate, sodium-dependent uptake ofthe amino
acid alanine is increased in endotoxemic rats [36] suggesting that alterations of the Na+-
K+-ATPase activity do not affect sodium-dependent transport in this model ofcholestasis.
Although the mechanisms of altered Na+-K+-ATPase activity in endotoxemia remain
unclear, decreased membrane fluidity as previously reported in endotoxemic shock might
play a role in the regulation of the enzyme activity [38]. In extrahepatic cholestasis
induced by common bile duct ligation, Na+-K+-ATPase activity seems to be slightly
increased after 3 days, but no detailed study has been published so far. Similar to other
cholestastic models, expression ofboth protein and mRNA levels ofthe catalytic al-sub-
unit ofthe Na+-K+-ATPase remained unchanged for up to 7 days ofbile duct ligation [39].
In summary, Na+-K+-ATPase activity is reduced at least in experimental models of intra-
hepatic cholestasis. However, several lines of evidence argue against any role of altered
Na+-K+-ATPase activity in the pathogenesis of reduced sodium-dependent taurocholate
uptake and diminished bile flow in cholestasis, especially as major alterations occur in
function and expression ofbile acid transporters as "down-stream" events during cholesta-
SiS.
MOLECULAR REGULATION OF THE NA+-DEPENDENT
BILE ACID TRANSPORTER IN CHOLESTASIS
So far the rat liver Na+/taurocholate cotransporting polypeptide (ntcp) represents
functionally and at the molecular level the best characterized bile acid transport system,
and serves as a paradigm for the study of other bile acid transporters under physiological
and pathophysiological conditions. Function and expression of this transport system have
been extensively characterized in models ofextrahepatic and intrahepatic cholestasis [30,
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Table 1: Effect ofvarious experimental models ofcholestasis on ntcp function and expression.
Animal model Transport Protein mass Steady-state mRNA Gene transcription
Bile duct ligation 4 (30%) 4-4 (< 10%) 4 (40-50%) 4 (20%)
Estrogen 4-4 (10%) 4 (~ 25%) 4- (50 %) n.d.
Endotoxin
3 days 4 (50%) 4 (~ 25%) 44- (< 15%) n.d.
16 hr 4-4-4- (absent) 4-4-4 (< 10%) 4-4-4- (< 10%) n.d.
Data were obtained from previous publications: bile duct ligation [39], estrogen [30], endotoxin (3
days [36]; 16 hours [37]). The number of arrows correlates with the extent ofdown-regulation. The
numbers given in parenthesis are percentage of sham-operated controls.
36, 37, 39]. In all of these experimental models of cholestasis, studies demonstrated spe-
cific down-regulation ofboth function and expression of ntcp in rat liver (Table 1).
In a model ofextrahepatic cholestasis induced by common bile duct ligation (CBDL),
ntcp protein mass virtually disappeared 3 days after common bile duct ligation, whereas
other basolateral proteins such as the al-subunit of the Na+-K+-ATPase and CE-9
remained unchanged by this form ofcholestasis. Down-regulation ofthe protein mass was
accompanied by a reduction in ntcp mRNA levels by 50 percent and gene transcriptional
activity by 80 percent ofcontrols. These results suggest both transcriptional and posttran-
scriptional regulation of the ntcp gene during cholestasis. Furthermore, changes in ntcp
expression resulted in a 70 percent decrease of sodium-dependent taurocholate uptake
[39].
In estrogen-induced cholestasis, initial sodium-dependent taurocholate uptake was
also significantly reduced. As early as 3 days after ethinyl estradiol (EE) treatment, sodi-
um-dependent taurocholate uptake declined by 40 percent of controls and was further
reduced by 90 percent after treatment had been extended for up to 7 days. Similar to sodi-
um-dependent taurocholate uptake, ntcp protein mass significantly declined by 45 percent
as compared to controls after 3 days, and was further reduced by 80 percent after 5 days
ofEE application. Two bands ofthe ntcp protein with an apparent molecular weight of56
kDa and 51 kDa were identified in sinusoidal membrane preparation, which presumably
represented two differentially glycosylated isoforms ofntcp, since deglycosylation result-
ed in a single band with an approximate molecular weight of 33 kDa. Whereas the high-
er glycosylated form ofntcp was rapidly reduced by 40 percent within 12 hr after the first
EE application, the major 51 kDa band remained unchanged until 5 days ofEE treatment,
when its protein content declined to 35 percent of control values. In contrast to the slow
decline in ntcp protein mass, steady-state mRNA levels of ntcp rapidly decreased by 50
percent ofcontrols within 12 hr of EE treatment, and remained at similar levels for up to
5 days [30].
Induction ofcholestasis by endotoxin or cytokines such as tumor necrosis factor alpha
(TNF-a) or interleukin 1 (IL-1i3) exhibited a similar effect on sodium-dependent tauro-
cholate uptake and ntcp protein and steady-state mRNA levels as described for cholestasis
induced by bile duct ligation or estrogens [36, 37]. After daily injection of endotoxin (E.
coli 0127:B8 LPS, 1 mg/kg body weight) for 3 days, Moseley et al. found a 50 percent
decrease in theVmax ofsodium-dependent taurocholate uptake, and areduction in ntcp pro-
tein mass by more than 70 percent and its mRNA by more than 85 percent of controls,
respectively. A similar decline was observed in the initial uptake rate of taurocholate and
the expression ofntcp mRNA 4 hours after application ofTNF-a [36]. Green et al. report-
ed that injection of a less potent form of LPS, although at a much higher dose (E. coli
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26:B6, 15 mg/kg body weight), resulted in non-detectable sodium-dependent taurocholate
uptake and a specific decline of ntcp protein mass and its steady-state mRNA levels by
more than 90 percent of control levels 16 hr after LPS injection. In a mouse model, injec-
tion of the proinflammatory cytokines TNF-ax and IL-1B decreased ntcp mRNA levels by
65 percent ofcontrols within 6 hrafter application. In contrast, various doses ofinterleukin-
6 did not affect ntcp mRNA in vivo similar to observation in isolated hepatocytes by the
same authors [40].
The results ofthese studies in various models ofexperimental cholestasis suggest that
liver cells in general respond to cholestasis by down-regulation of their basolateral Na+-
dependent bile acid uptake system. Clinical relevance of this finding is implicated by a
recent publication of Shneider and co-workers, who reported a marked down-regulation
ofNTCP-mRNA in patients with biliary atresia, a disease, in which extrahepatic bile duct
obstruction occurs [41]. Since decreased ntcp expression results in significantly reduced
Na+-dependent uptake ofbile acids, which accounts physiologically for approximately 90
percent of conjugated bile acid uptake, it can be speculated that down-regulation of
ntcp/NTCP represents a protective mechanism by which the hepatocytes minimize the
uptake of bile acids and limit their hepatotoxicity during cholestasis.
Whereas TNF-x, IL-113 and estrogens have to be regarded as potential regulators of
the ntcp gene during intrahepatic cholestasis, no specific factors have been identified so
far as regulators ofntcp in extrahepatic cholestasis. However, studies in various models of
bile retention and depletion suggest that retention of biliary constituents plays an impor-
tant role in the regulation of the ntcp gene. In all models of bile retention including the
choledochocaval fistula and the selective bile duct ligated rat, ntcp expression was down-
regulated as long as biliary constituents were increased in the serum and presumably
retained within the liver [42]. In selective bile duct ligated rats, down-regulation of ntcp
mRNA levels was confined to the obstructed liver lobes, whereas ntcp mRNA remained
unchanged in open liver lobes in this cholestastic model. As shown by regression analysis
of data combined from all surgical cholestasis and retention models, the decrease in ntcp
steady-state mRNA levels correlates linearly with serum bile acid levels in the 0-100
,umol/l range [42]. Although no specific compounds in bile have been identified which
regulate ntcp expression in vivo, preliminary studies using the cloned ntcp promoter have
shown suppression ofntcp promoter activity by various bile acids [43, 44].
MOLECULAR REGULATION OF THE ORGANIC ANION TRANSPORTING
POLYPEPTIDE OATP-1 IN CHOLESTASIS
In addition to sodium-dependent transport, bile acids and other organic anions are
taken up into the liver cells by a sodium-independent transportmechanism. Although sev-
eral organic anion transporters have functionally been identified, the numbers and types
of transporters and their substrate specificity remain controversial [6]. The cloned oatp-
1 has been shown to mediate the sodium-independent uptake of a variety of conjugated
and unconjugated bile acids [13]. Less well characterized than ntcp in cholestasis, oatp-
1 protein and steady-state mRNA levels are also down-regulated after estrogen treatment,
but no change was observed in the sodium-dependent uptake of taurocholate for up to 7
days [30]. Although estrogen treatment resulted in a rapid decrease in oatp-J mRNA by
72 percent ofcontrols within 12 hr and a further decline by 90 percent after 5 days, oatp-
1 protein mass was still detectable after 5 days of EE treatment reaching 38 percent of
control levels. These data suggest that either a decrease in oatp-1 protein mass does not
correlate with its transport ability within a certain range or that oatp-1 does not play an
important role in the overall sodium-independent transport of bile acids. Alternatively,
loss in oatp-1 transport activity due to its decreased protein expression might be com-
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pensated by additional organic anion transporters (e.g., the recently cloned oatp-4 [7]),
which remain functionally unaffected by cholestasis. Preliminary studies in cholestasis
induced by common bile duct ligation would support the latter hypothesis, since down-
regulation ofoatp-1 protein and its steady-state mRNA by bile duct ligation did not affect
sodium-independent uptake of bile acids [45].
CONCLUSIONS
The cloning of sinusoidal bile acid and organic anion transporters has opened a new
era in our understanding of the pathophysiology of cholestasis. The identification of the
canalicular multiorganic anion transporter (cMOAT/mrp2) as a liver homologue of the
multidrug resistance-associated protein and the study of its regulation in cholestasis [46]
has added another piece ofthe puzzle. The cloning of theATP-dependent canalicular bile
acid transporter will finally close a major gap in studying hepatic plasma membrane bile
salt transport under physiologic and pathophysiologic conditions. With the availability of
human probes, expression of bile acid and organic anion transporters can be determined
in various human liver diseases including cholestatic syndromes.
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